Sites: CDL-Oxford, CDL-Seattle, CDL-Toronto, CDL-Vancouver
Stream: Advanced Therapies
Patrick Bedford is an experienced and certified regulatory professional who is focused on facilitating global regenerative medicine developments. He is a VP (Regulatory Strategy) at a CRISPR-enabled multiplex cell engineering company that supports cell therapy applications, and he leads an emerging regulatory consulting company that provides regulatory planning, submission, and advisory services.
Patrick previously supported cell & gene therapy start-up teams; led New Drug Submissions for industry; and developed Health Canada policies for biosimilars, transplant material, and cell & gene therapies. While leading these policy initiatives, Patrick also supported product classification and international harmonization initiatives. He remains an active educator and contributor to regulatory policy development in Canada.